
US Oncology Research Achieves Milestone of Over 100 FDA-Approved Cancer Therapies

Available in patients’ own communities, novel clinical trials are making an impact in the fight against cancer.
THE WOODLANDS, Texas —
“US Oncology Research’s core mission is to bring potentially life-saving and life-improving treatments to the community where patients seek care,” said Robert L. Coleman, MD, FACOG, FACS, chief scientific officer, US Oncology Research. “These new interventions come from expert stewardship and execution of clinical research protocols positioned to better understand cancer biology and challenge the status quo. We are, therefore, incredibly proud of this milestone, which reflects the dedication and collective spirit of investigators across
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.